Plasma t-tau level as a biomarker for survival time in those with sporadic Creutzfeldt-Jakob disease

Takeaway

  • Plasma total tau level may be a fluid biomarker in sporadic Creutzfeldt-Jakob disease (sCJD) that could improve clinical trial design and clinical management.

Why this matters

  • Fluid biomarkers that predict life expectancy in sCJD are critical for clinical management and treatment studies.